Stock Rating Downgrade The Value Trend Rating for GeoPark Ltd (NYSE: GPRK) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Stock Rating Upgrade Of late the Value Trend Rating for Flotek Industries Inc (NYSE: FTK) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action Flotek Industries Inc (NYSE: FTK) […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Crexendo Inc (NASDAQ: CXDO) improved of late. CXDO’s current Value Trend Rating is B and the prior Rating was C. […]
Stock Rating Downgrade The Value Trend Rating for Crawford & Co (NYSE: CRD.A) weakened recently from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Upgrade Of late the Value Trend Rating for Boise Cascade Co (NYSE: BCC) rose significantly from F to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 3/14/25, Boise Cascade […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for B&G Foods Inc (NYSE: BGS) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On […]
Atlanticus Holdings Corp (NASDAQ: ATLC) stock closed at $48.64 on 3/14/25 after a major increase of 11.3%. Moreover, above average trading volume at 142% of normal accompanied the advance. The stock has risen 6.5% during […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) rose significantly recently. AZN’s current Value Trend Rating is C and the prior Rating was F. […]
Stock Rating Upgrade The Value Trend Rating for Amkor Technology Inc (NASDAQ: AMKR) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]
Stock Rating Upgrade Of late the Value Trend Rating for Acadia Pharmaceuticals Inc (NASDAQ: ACAD) rose significantly from F to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 3/14/25, Acadia Pharmaceuticals […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research